The document provides an overview of the emerging healthcare landscape in India. It discusses key trends like rising costs of care, low insurance penetration rates, and a large uninsured population. It also summarizes recent regulatory changes affecting various sectors and outlines strategies companies are adopting in response to increased genericization, like expanding into new areas such as OTC, ayurveda, and supplements. The National Health Protection Scheme aims to increase insurance coverage and address issues of access and affordability.
This is a report about Indian Health care industry and How different sectors like Hospitals, Pharmacy and Diagnostics industry are growing. What are the new government policies that are implemented for Health care sector in India.
The document provides an overview of the Indian healthcare system, including key trends, growth drivers, and challenges. It notes that the size of the Indian healthcare industry is $35 billion and growing at 17% annually, faster than any other country. The industry employs over 4% of the population and includes 229 medical colleges, 600,000 doctors, and over 800,000 hospital beds. However, healthcare infrastructure and access remains inadequate, with 80% of healthcare spending being out-of-pocket. The government is taking steps to improve access through initiatives like the National Rural Health Mission and increasing healthcare spending.
Narayana hrudayala heart hospital Business StrategyAshis Sarangi
The slide include how Devi Shetty implemented his business strategy in order to position his trust among all by giving below cost quality care and in order to compensate the investment, he indirectly targeted rural areas in the form of insurance scheme and also the scheme helped him in planing to expand his business for long time sustainability.
The document provides an industry analysis of Apollo Hospitals in India. It discusses the size and growth of the healthcare industry in India. Key facts noted include that the industry is currently worth $34 billion and is projected to grow to $40 billion by 2022. It also profiles the chairman of Apollo Hospitals, Dr. Prathap Reddy, and his vision to make India a healthcare destination. Details are given on some major players in the hospital industry like Fortis, Max India and Escorts. Apollo Hospitals is highlighted as a leading private healthcare provider in Asia with over 7500 beds across 43 hospitals in India and abroad.
Evolution of the healthcare industry in India and the potential impact of the...Harshit Jain
2014 looks to be a positive but challenging year for the Indian health care sector; one in which many historic business models and operating processes will no longer suffice amid rising demand, continued cost pressures, lack of or inadequate care facilities, and rapidly evolving market conditions. India, likely will be dominated by the “Modi-care” –Health assurance for all.
The document provides an industry analysis of Apollo Hospitals, a leading private healthcare provider in India. It discusses the healthcare industry in India and key players. Apollo Hospitals was established in 1983 and today has over 7500 beds across 43 hospitals in India and overseas. It provides a wide range of healthcare services including hospitals, clinics, pharmacies, insurance, and education and aims to make India a global healthcare destination. The document outlines Apollo's business units and services.
Financial analysis of saving cost with 3D printing Materialise NV
Medical 3D Printing Cost-Savings in
Orthopedic and Maxillofacial Surgery:
Cost Analysis of Operating Room
Time Saved with 3D Printed Anatomic
Models and Surgical Guides
Apollo Hospital (Brand legacy, Mission, Vision , Strategies for expansion )Eliza Manandhar
1) Apollo Hospitals was established in 1983 in India and has since grown to become Asia's largest healthcare group with over 8,500 beds across 50 hospitals in India and other countries.
2) The group's vision is to "Touch a billion lives" by bringing affordable, high-quality healthcare through an integrated network of hospitals, clinics, pharmacies, and other services.
3) Apollo Hospitals has pioneered many innovations in India such as telemedicine, robotic surgery, and being the first hospital in the country to receive international accreditation and recognition as a top medical tourism facility.
This is a report about Indian Health care industry and How different sectors like Hospitals, Pharmacy and Diagnostics industry are growing. What are the new government policies that are implemented for Health care sector in India.
The document provides an overview of the Indian healthcare system, including key trends, growth drivers, and challenges. It notes that the size of the Indian healthcare industry is $35 billion and growing at 17% annually, faster than any other country. The industry employs over 4% of the population and includes 229 medical colleges, 600,000 doctors, and over 800,000 hospital beds. However, healthcare infrastructure and access remains inadequate, with 80% of healthcare spending being out-of-pocket. The government is taking steps to improve access through initiatives like the National Rural Health Mission and increasing healthcare spending.
Narayana hrudayala heart hospital Business StrategyAshis Sarangi
The slide include how Devi Shetty implemented his business strategy in order to position his trust among all by giving below cost quality care and in order to compensate the investment, he indirectly targeted rural areas in the form of insurance scheme and also the scheme helped him in planing to expand his business for long time sustainability.
The document provides an industry analysis of Apollo Hospitals in India. It discusses the size and growth of the healthcare industry in India. Key facts noted include that the industry is currently worth $34 billion and is projected to grow to $40 billion by 2022. It also profiles the chairman of Apollo Hospitals, Dr. Prathap Reddy, and his vision to make India a healthcare destination. Details are given on some major players in the hospital industry like Fortis, Max India and Escorts. Apollo Hospitals is highlighted as a leading private healthcare provider in Asia with over 7500 beds across 43 hospitals in India and abroad.
Evolution of the healthcare industry in India and the potential impact of the...Harshit Jain
2014 looks to be a positive but challenging year for the Indian health care sector; one in which many historic business models and operating processes will no longer suffice amid rising demand, continued cost pressures, lack of or inadequate care facilities, and rapidly evolving market conditions. India, likely will be dominated by the “Modi-care” –Health assurance for all.
The document provides an industry analysis of Apollo Hospitals, a leading private healthcare provider in India. It discusses the healthcare industry in India and key players. Apollo Hospitals was established in 1983 and today has over 7500 beds across 43 hospitals in India and overseas. It provides a wide range of healthcare services including hospitals, clinics, pharmacies, insurance, and education and aims to make India a global healthcare destination. The document outlines Apollo's business units and services.
Financial analysis of saving cost with 3D printing Materialise NV
Medical 3D Printing Cost-Savings in
Orthopedic and Maxillofacial Surgery:
Cost Analysis of Operating Room
Time Saved with 3D Printed Anatomic
Models and Surgical Guides
Apollo Hospital (Brand legacy, Mission, Vision , Strategies for expansion )Eliza Manandhar
1) Apollo Hospitals was established in 1983 in India and has since grown to become Asia's largest healthcare group with over 8,500 beds across 50 hospitals in India and other countries.
2) The group's vision is to "Touch a billion lives" by bringing affordable, high-quality healthcare through an integrated network of hospitals, clinics, pharmacies, and other services.
3) Apollo Hospitals has pioneered many innovations in India such as telemedicine, robotic surgery, and being the first hospital in the country to receive international accreditation and recognition as a top medical tourism facility.
This document provides an overview of the branded generics pharmaceutical market in India and the company Mankind Pharma. It summarizes Mankind's growth and success in the Indian market through organic expansion of its field force and market share, growing its portfolio of branded generic drugs, and expanding globally to over 12 countries. Key metrics shown include its rising domestic market share and rankings over time, high growth rates compared to industry averages, and leadership in key therapeutic segments like anti-diabetics and cardiac drugs.
The document provides an overview and analysis of the pathology industry in India. Some key points:
1) The pathology sector in India is expected to grow at a CAGR of 16-18% and reach 400-500 billion INR in the next 3 years, driven by factors like increasing healthcare awareness, shift to chronic diseases, and growth in health insurance coverage.
2) The industry is currently highly fragmented with many small standalone laboratories. Major organized players are expanding use franchising models and hub-and-spoke networks to increase coverage.
3) Key trends driving growth include the shift from infectious to lifestyle diseases, increasing use of technology like telemedicine and automation, and government initiatives to strengthen the healthcare system
This document provides an analysis of the healthcare industry in India. It includes:
1) An overview of the size and growth of the healthcare industry in India, which contributes 5.25% to GDP and is projected to grow at 23% annually.
2) A brief history of healthcare in India including Ayurveda, Homeopathy, and the introduction of Allopathy.
3) An analysis of the key players in the industry based on number of beds, including Apollo Hospitals, Fortis Healthcare, and Max Hospitals.
4) A Porter's Five Forces analysis of the industry which finds increasing competition among players and a mismatch between the growing demand and limited supply of healthcare services in
Medtronic is a medical technology company that develops life-changing technologies to treat chronic diseases. They work closely with physicians around the world and have six major business units focused on different medical conditions and therapies. Medtronic serves medical professionals by developing innovative technologies and uses a blend of Lean and Six Sigma practices in their business model. They are constantly innovating both new technologies and business processes to improve patient care and lives.
Narayana hrudayalaya :the low cost and high quality service providerSmruthy Gowda
Narayana Health was founded in 2001 by Dr. Devi Shetty to provide high quality and affordable healthcare to more people in India. It has expanded to 23 hospitals across 14 cities. Narayana Health is known for innovations like economies of scale, shared resources, and telemedicine to reduce costs. Under the leadership of Dr. Shetty, Narayana Health has performed over 99,000 cardiac surgeries and aims to make quality healthcare accessible to more people in India.
Presentation on the history of border changes in Armenia and the South Caucasus. See http://www.slideshare.net/jurban16/armenia-71044692 for the main presentation from which this presentation was excerpted.
Electronic health records and machine learningEman Abdelrazik
Electronic health records and machine learning can be used together to generate real-world evidence. Real-world data is collected from electronic health records in real clinical settings and can provide insights into a treatment's effectiveness and safety outside of clinical trials. Machine learning models can analyze structured and unstructured data in electronic health records to identify patterns and make predictions. This can help with tasks like medical diagnosis, which is challenging due to variations between individuals and potential for misdiagnosis. However, developing accurate machine learning models requires addressing issues like selecting representative training data and setting performance standards.
NH mission is to deliver high-quality, affordable healthcare services to the broader population by leveraging economies of scale, skilled doctors, and an efficient business model
The document discusses strategic alliances and joint ventures between pharmaceutical companies. It provides details of four examples of partnerships: Merck partnered with Alnylam in a non-equity strategic alliance to collaborate on RNAi drug development. GSK partnered with Dong-A through an equity strategic alliance to co-promote products in South Korea. Hisun and Pfizer formed a joint venture to collaborate on local production and distribution in China. Intrexon partnered with Sun Pharmaceuticals through a joint venture to develop new methods for treating ocular diseases using synthetic biology.
The document discusses the results of a study on the effects of a new drug on memory and cognitive function in older adults. The double-blind study involved 100 participants aged 65-80 who were given either the drug or a placebo daily for 6 months. Researchers found that those who received the drug performed significantly better on memory and problem-solving tests at the end of the study compared to those who received the placebo.
Amul is India's largest dairy cooperative and milk producer. It collects milk from 2.6 million farmers every day and converts it into branded, packaged products. Amul has a diverse product portfolio including milk, butter, ghee, cheese, chocolate, and ice cream. It has a robust supply chain and distribution network of over 500,000 retail outlets across India. Amul pursues a low-cost strategy to make its products affordable and uses promotional campaigns like the iconic Amul girl advertisements to increase brand awareness. It faces competition from other dairy companies but maintains its market leadership through quality products and a strong farmer network.
Market entry strategy for medical devices SME's in AsiaShikharesh Das
Ontogenix is a Singapore-based consulting firm that provides market entry and implementation services to medical device and life sciences companies seeking growth in Asia and beyond. They have expertise in market research, regulatory strategy, and distributor search and management. Their team of experienced consultants can help clients develop strategies for entering new markets and finding distribution partners in over 80% of global markets.
HCG adopted a focused factory model for cancer care in India called the "hub and spoke" model. This model provided centralized specialized cancer treatment and technologies at hub locations, while basic therapies and follow-ups were provided at smaller spoke locations close to patients' communities. This improved access, reduced costs of travel, and allowed for consistent treatment. HCG also focused on quality, training, and reducing costs through centralized procurement to make specialized cancer care more affordable and accessible across India.
This document summarizes a project on customer buying behavior for dairy products in India. It discusses the dairy industry in India, objectives of the study, methodology used which was a survey of 72 customers. It analyzes the data collected on customer demographics, spending habits, preferred brands and products. Key findings are that customers prioritize quality over price, are not fully loyal to brands, and there is an opportunity for the dairy industry to expand availability. Suggestions include improving supply chain efficiency and focusing on reaching underserved customer segments.
Teva Pharmaceutical Industries is the world's largest generic drug company. It has a history dating back to 1901 and was formed through mergers and acquisitions of several Israeli pharmaceutical companies in the mid-20th century. Teva has expanded significantly through acquisitions globally to become a leader in generic and branded drugs, with major acquisitions including Ivax, Barr, Ratiopharm, Cephalon, and more. It has a portfolio of generic drugs and treatments for conditions like multiple sclerosis, Parkinson's disease, cancer, and more.
Supply and chain management of itc companyPujan Vora
This will help you to get information about ITC company. In this presentation there are many points are like Distribution channel, inventory, Transportation and How it take cost advantages from Market.
Chhattisgarh has a strong mineral production base and is a leading producer of coal and iron ore in India. It is the only state that produces tin concentrates. Korba district is known as the power capital of India. The state has emerged as a startup hub with sectors like ecommerce growing. Between 2011-2012 and 2017-2018, the gross value added from the primary sector grew at a CAGR of 9.88%. Chhattisgarh has experienced strong economic growth and is considered one of the best managed states in India.
Mankind Pharma is an Indian pharmaceutical company that was founded in 1995 with a goal of providing quality medicines at affordable prices. It has since grown to become the 8th largest drug manufacturer in India with a diverse portfolio that includes medicines, veterinary products, and personal care items. Mankind employs an aggressive marketing strategy focused on rural areas using a large network of medical representatives. Their competitive advantages include offering low prices tailored to price-sensitive rural customers, and an emphasis on marketing and sales over research. Their growth strategy focuses on international expansion while continuing to strengthen their portfolio and tackle industry challenges.
Product-Mix & Product line analysis of United Phosphorus Ltd..Bidhu Bhushan Binit
Here herbicide product line analysis of UPL has been done to find out the line decisions of the company and accordingly suggestions have been given on line stretching, line filling and line modernization. Since price-list and sales figures are not available, so line pruning decision has not been done.
The document provides an overview of the emerging healthcare landscape in India. It discusses key trends like rising healthcare costs, low insurance penetration rates, and a large rural-urban healthcare access gap. It also summarizes recent regulatory changes affecting drugs, medical devices and the introduction of the National Health Protection Scheme to expand health insurance coverage. If genericization increases in India, it could significantly impact the pharmaceutical industry structure and market share of large domestic and global players. Companies may need to diversify product portfolios and sales strategies to adapt to a more generic dominated market.
UC STRATEGY is approached by many Indian and global Life Sciences and Pharmaceutical companies to develop winning Life Sciences and Pharmaceuticals strategies.
This document provides an overview of the branded generics pharmaceutical market in India and the company Mankind Pharma. It summarizes Mankind's growth and success in the Indian market through organic expansion of its field force and market share, growing its portfolio of branded generic drugs, and expanding globally to over 12 countries. Key metrics shown include its rising domestic market share and rankings over time, high growth rates compared to industry averages, and leadership in key therapeutic segments like anti-diabetics and cardiac drugs.
The document provides an overview and analysis of the pathology industry in India. Some key points:
1) The pathology sector in India is expected to grow at a CAGR of 16-18% and reach 400-500 billion INR in the next 3 years, driven by factors like increasing healthcare awareness, shift to chronic diseases, and growth in health insurance coverage.
2) The industry is currently highly fragmented with many small standalone laboratories. Major organized players are expanding use franchising models and hub-and-spoke networks to increase coverage.
3) Key trends driving growth include the shift from infectious to lifestyle diseases, increasing use of technology like telemedicine and automation, and government initiatives to strengthen the healthcare system
This document provides an analysis of the healthcare industry in India. It includes:
1) An overview of the size and growth of the healthcare industry in India, which contributes 5.25% to GDP and is projected to grow at 23% annually.
2) A brief history of healthcare in India including Ayurveda, Homeopathy, and the introduction of Allopathy.
3) An analysis of the key players in the industry based on number of beds, including Apollo Hospitals, Fortis Healthcare, and Max Hospitals.
4) A Porter's Five Forces analysis of the industry which finds increasing competition among players and a mismatch between the growing demand and limited supply of healthcare services in
Medtronic is a medical technology company that develops life-changing technologies to treat chronic diseases. They work closely with physicians around the world and have six major business units focused on different medical conditions and therapies. Medtronic serves medical professionals by developing innovative technologies and uses a blend of Lean and Six Sigma practices in their business model. They are constantly innovating both new technologies and business processes to improve patient care and lives.
Narayana hrudayalaya :the low cost and high quality service providerSmruthy Gowda
Narayana Health was founded in 2001 by Dr. Devi Shetty to provide high quality and affordable healthcare to more people in India. It has expanded to 23 hospitals across 14 cities. Narayana Health is known for innovations like economies of scale, shared resources, and telemedicine to reduce costs. Under the leadership of Dr. Shetty, Narayana Health has performed over 99,000 cardiac surgeries and aims to make quality healthcare accessible to more people in India.
Presentation on the history of border changes in Armenia and the South Caucasus. See http://www.slideshare.net/jurban16/armenia-71044692 for the main presentation from which this presentation was excerpted.
Electronic health records and machine learningEman Abdelrazik
Electronic health records and machine learning can be used together to generate real-world evidence. Real-world data is collected from electronic health records in real clinical settings and can provide insights into a treatment's effectiveness and safety outside of clinical trials. Machine learning models can analyze structured and unstructured data in electronic health records to identify patterns and make predictions. This can help with tasks like medical diagnosis, which is challenging due to variations between individuals and potential for misdiagnosis. However, developing accurate machine learning models requires addressing issues like selecting representative training data and setting performance standards.
NH mission is to deliver high-quality, affordable healthcare services to the broader population by leveraging economies of scale, skilled doctors, and an efficient business model
The document discusses strategic alliances and joint ventures between pharmaceutical companies. It provides details of four examples of partnerships: Merck partnered with Alnylam in a non-equity strategic alliance to collaborate on RNAi drug development. GSK partnered with Dong-A through an equity strategic alliance to co-promote products in South Korea. Hisun and Pfizer formed a joint venture to collaborate on local production and distribution in China. Intrexon partnered with Sun Pharmaceuticals through a joint venture to develop new methods for treating ocular diseases using synthetic biology.
The document discusses the results of a study on the effects of a new drug on memory and cognitive function in older adults. The double-blind study involved 100 participants aged 65-80 who were given either the drug or a placebo daily for 6 months. Researchers found that those who received the drug performed significantly better on memory and problem-solving tests at the end of the study compared to those who received the placebo.
Amul is India's largest dairy cooperative and milk producer. It collects milk from 2.6 million farmers every day and converts it into branded, packaged products. Amul has a diverse product portfolio including milk, butter, ghee, cheese, chocolate, and ice cream. It has a robust supply chain and distribution network of over 500,000 retail outlets across India. Amul pursues a low-cost strategy to make its products affordable and uses promotional campaigns like the iconic Amul girl advertisements to increase brand awareness. It faces competition from other dairy companies but maintains its market leadership through quality products and a strong farmer network.
Market entry strategy for medical devices SME's in AsiaShikharesh Das
Ontogenix is a Singapore-based consulting firm that provides market entry and implementation services to medical device and life sciences companies seeking growth in Asia and beyond. They have expertise in market research, regulatory strategy, and distributor search and management. Their team of experienced consultants can help clients develop strategies for entering new markets and finding distribution partners in over 80% of global markets.
HCG adopted a focused factory model for cancer care in India called the "hub and spoke" model. This model provided centralized specialized cancer treatment and technologies at hub locations, while basic therapies and follow-ups were provided at smaller spoke locations close to patients' communities. This improved access, reduced costs of travel, and allowed for consistent treatment. HCG also focused on quality, training, and reducing costs through centralized procurement to make specialized cancer care more affordable and accessible across India.
This document summarizes a project on customer buying behavior for dairy products in India. It discusses the dairy industry in India, objectives of the study, methodology used which was a survey of 72 customers. It analyzes the data collected on customer demographics, spending habits, preferred brands and products. Key findings are that customers prioritize quality over price, are not fully loyal to brands, and there is an opportunity for the dairy industry to expand availability. Suggestions include improving supply chain efficiency and focusing on reaching underserved customer segments.
Teva Pharmaceutical Industries is the world's largest generic drug company. It has a history dating back to 1901 and was formed through mergers and acquisitions of several Israeli pharmaceutical companies in the mid-20th century. Teva has expanded significantly through acquisitions globally to become a leader in generic and branded drugs, with major acquisitions including Ivax, Barr, Ratiopharm, Cephalon, and more. It has a portfolio of generic drugs and treatments for conditions like multiple sclerosis, Parkinson's disease, cancer, and more.
Supply and chain management of itc companyPujan Vora
This will help you to get information about ITC company. In this presentation there are many points are like Distribution channel, inventory, Transportation and How it take cost advantages from Market.
Chhattisgarh has a strong mineral production base and is a leading producer of coal and iron ore in India. It is the only state that produces tin concentrates. Korba district is known as the power capital of India. The state has emerged as a startup hub with sectors like ecommerce growing. Between 2011-2012 and 2017-2018, the gross value added from the primary sector grew at a CAGR of 9.88%. Chhattisgarh has experienced strong economic growth and is considered one of the best managed states in India.
Mankind Pharma is an Indian pharmaceutical company that was founded in 1995 with a goal of providing quality medicines at affordable prices. It has since grown to become the 8th largest drug manufacturer in India with a diverse portfolio that includes medicines, veterinary products, and personal care items. Mankind employs an aggressive marketing strategy focused on rural areas using a large network of medical representatives. Their competitive advantages include offering low prices tailored to price-sensitive rural customers, and an emphasis on marketing and sales over research. Their growth strategy focuses on international expansion while continuing to strengthen their portfolio and tackle industry challenges.
Product-Mix & Product line analysis of United Phosphorus Ltd..Bidhu Bhushan Binit
Here herbicide product line analysis of UPL has been done to find out the line decisions of the company and accordingly suggestions have been given on line stretching, line filling and line modernization. Since price-list and sales figures are not available, so line pruning decision has not been done.
The document provides an overview of the emerging healthcare landscape in India. It discusses key trends like rising healthcare costs, low insurance penetration rates, and a large rural-urban healthcare access gap. It also summarizes recent regulatory changes affecting drugs, medical devices and the introduction of the National Health Protection Scheme to expand health insurance coverage. If genericization increases in India, it could significantly impact the pharmaceutical industry structure and market share of large domestic and global players. Companies may need to diversify product portfolios and sales strategies to adapt to a more generic dominated market.
UC STRATEGY is approached by many Indian and global Life Sciences and Pharmaceutical companies to develop winning Life Sciences and Pharmaceuticals strategies.
The document provides an overview of the pharmaceutical sector in India. It discusses key trends in the Indian pharmaceutical market including growing demand, cost advantages, policy support, and a diversified product portfolio. It also outlines the structure and evolution of the pharmaceutical industry in India. The generics market is the largest segment and anti-infectives lead in terms of market share. Exports are a major focus and have grown significantly in recent years. The top firms invest heavily in R&D and account for over 20% of the domestic market.
- India is a leading producer of pharmaceuticals, accounting for around 2.4% of global pharma production by value and 10% by volume. It exports $16.89 billion worth of drugs annually.
- The Indian pharma market was worth $36.7 billion in 2016 and is expected to reach $55 billion by 2020, growing at a CAGR of 12.89%. Generics account for 70% of the domestic market.
- India has a large, diverse pharma industry with over 60,000 generic brands across 60 therapeutic categories. Production costs are much lower than in Western markets, boosting Indian competitiveness.
The document provides an overview of key trends in the Indian pharmaceutical sector:
- Indian pharmaceutical companies are increasing spending on research and development between 8-11% of total turnover to develop new drugs and boost sales.
- Pharmaceutical exports from India are thriving, particularly in generics, with exports exceeding $15 billion in 2015 and reaching $16.89 billion in 2016.
- Multinational companies are collaborating with Indian firms through joint ventures to develop new drugs, while Indian players are also expanding operations abroad.
The document provides an overview of the pharmaceutical sector in India. Some key points:
- India is a leading global producer of generic drugs and vaccines, accounting for 20% of global exports. The domestic market was worth $36.7 billion in 2016 and is forecast to reach $55 billion by 2020.
- The sector benefits from low production costs which are 60% lower than the US and half of Europe. Government policies also support the growth of the sector.
- Generics account for 70% of the domestic market, while chronic therapies like cardiovascular, anti-diabetic, and anti-infectives are major segments. Exports and domestic demand are driving continued expansion of the industry.
The document provides information on the pharmaceutical sector in India. Some key points:
- India accounts for approximately 10% of global pharmaceutical production and is the largest provider of generic medicines globally. Exports of pharmaceutical products from India reached USD 16.89 billion in FY2016.
- The domestic pharmaceutical market was worth USD 27.57 billion in 2016 and is expected to reach USD 55 billion by 2020, growing at a CAGR of 12.89% from 2015-2020. Generics account for 70% of the domestic market.
- Leading players like Dr. Reddy's, Lupin, Cipla and Aurobindo account for over 20% of the domestic market. Top companies are
The document provides an overview of the Indian healthcare sector as of June 2017. Some key points:
- The Indian healthcare sector is expected to grow at a CAGR of 26.31% until 2020 to reach $280 billion.
- Private sector accounts for around 74% of total healthcare spending in India.
- Per capita healthcare expenditure has risen at a CAGR of 5% from 2010-2015 reaching $68.6 in 2015.
- Major players like Apollo Hospitals and Aravind Eye Hospitals have a pan-India presence operating numerous facilities across the country.
The document provides an overview of the pharmaceutical industry in India. Some key points:
- India is a major global supplier of generic drugs, accounting for 20% of global exports. The pharmaceutical industry is expected to grow to $55 billion by 2020 from $27.57 billion in 2016.
- The industry benefits from low production costs, which are 60% lower than the US and half of Europe. Government policies also support the industry through initiatives like 'Pharma Vision 2020'.
- Generics account for 70% of the domestic pharmaceutical market. The largest segments by therapy are anti-infectives at 16%, cardiovascular at 13%, and gastrointestinal at 11%.
The healthcare sector in India was valued at US$79 billion in 2012 and is expected to reach US$160 billion by 2017, growing at 15% annually. It accounts for 71% of total healthcare revenues and is one of India's largest employment sectors. Key drivers of growth include a growing middle class with rising incomes, increased lifestyle diseases, greater health awareness and insurance penetration. However, challenges remain around increasing access to insurance, controlling costs, and addressing shortages of qualified medical professionals concentrated in urban areas. The government is taking steps to encourage private sector investment and increase rural healthcare infrastructure to help overcome these challenges and further develop this important and growing sector.
This document provides an overview of the history and growth of the Indian pharmaceutical industry. It discusses how India's growing middle class and economy have increased healthcare spending and demand for drugs. It also summarizes how disease profiles are shifting towards more chronic conditions like diabetes. Government policies aim to improve healthcare access and spending. The pharmaceutical market and exports have grown significantly in recent decades and India has become a major supplier of generic drugs globally.
The document summarizes key information about India's healthcare sector:
- The Indian healthcare sector is growing rapidly, expected to reach USD280 billion by 2020 at a CAGR of 22.87%, fueled by rising incomes, aging population, growing health awareness and changing attitudes towards preventive healthcare.
- Private sector players have a strong presence in India's healthcare sector, accounting for around 74% of total healthcare expenditure. Major private hospital chains include Apollo Hospitals, Aravind Eye Hospitals, and CARE Hospitals.
- Per capita healthcare spending has risen significantly in recent years and is estimated at USD68.6 in 2015, reflecting greater affordability and penetration of health insurance.
The document provides an overview of the Indian healthcare sector. It discusses the following key points in 3 or fewer sentences:
- The Indian healthcare sector is growing rapidly, expected to reach USD280 billion by 2020 at a CAGR of 22.87%. There is significant room for growth given low penetration of healthcare services currently.
- Private sector accounts for around 74% of healthcare spending in India and owns around 74% of hospitals and 40% of hospital beds. Growth is driven by rising incomes, health awareness, and insurance penetration.
- Notable trends include a shift from communicable to lifestyle diseases, expansion of major players to tier-2 and -3 cities, increased use of telemedicine, growth of
The healthcare sector in India is poised for strong growth driven by rising incomes, an aging population, growing health awareness, and policy support. Key factors fueling growth include a growing demand for healthcare services as incomes rise and diseases patterns change. The sector is also attracting significant private sector investments through mergers and acquisitions as well as from foreign players setting up R&D centers and hospitals in India. The government is also encouraging growth in the sector through favorable policies for foreign investment and the private sector as well as programs to expand health insurance coverage and healthcare infrastructure across the country. The sector is expected to reach $372 billion by 2022 from $110 billion in 2016, growing at a 22% CAGR.
- The Indian healthcare sector is expected to grow at a CAGR of 22.87% until 2020 to reach $280 billion. Rising incomes, increasing health awareness, and changing attitudes towards preventive healthcare are driving demand.
- Private sector participation is significant, accounting for around 74% of total healthcare expenditure. Large private sector investments are contributing to the development of hospitals.
- Per capita healthcare expenditure has risen at a CAGR of 5% between 2008-2015 driven by economic growth, insurance penetration, and improved access and quality of facilities. However, India still lags global standards on healthcare access and spending.
The document provides an overview of the pharmaceutical sector in India. Some key points:
- India accounts for 10% of global pharmaceutical production and 20% of global generics exports. Exports grew 9.44% in FY2016 to $16.89 billion.
- The domestic market was worth $27.57 billion in 2016 and is projected to reach $55 billion by 2020, growing at a CAGR of 12.89%. Generics account for 70% of the market.
- Major players include Dr. Reddy's, Lupin, Cipla and Aurobindo, who collectively account for over 20% of the market. Companies are increasing R&D spending to develop new drugs
The healthcare sector in India is poised for strong growth over the coming years. Key points:
- The Indian healthcare market is expected to reach US$ 372 billion by 2022, growing at a CAGR of over 16%. Rising incomes, greater health awareness, and lifestyle diseases are driving demand.
- Infrastructure is also expanding rapidly with the number of doctors increasing to over 841,000 in 2017 and medical colleges reaching 476 in 2018.
- The government has also introduced favorable policies like tax benefits and increased funding to encourage private sector growth and increase healthcare access across the country through programs like Ayushman Bharat.
- Emerging trends include a shift to non-communicable diseases
The document provides information on trends in the Indian pharmaceutical sector:
- R&D spending by major Indian pharmaceutical companies is increasing, with Sun Pharma spending the most at $352 million in FY16. Lupin expects R&D spending to be 12-15% of sales in FY17.
- Exports of pharmaceutical products from India have been rapidly growing and exceeded $16.89 billion in FY16, expected to reach $40 billion by 2020. Generic drugs account for 20% of global exports by volume.
- The top four pharmaceutical companies in India - Dr. Reddy's, Lupin, Cipla, and Aurobindo - captured over 20% of the
The document provides an overview of trends in the Indian healthcare sector. Some key trends include:
1) Telemedicine is emerging rapidly, with major hospitals adopting telemedicine services to bridge rural-urban divides. The telemedicine market is expected to grow at 20% annually.
2) Healthcare providers are expanding to tier 2 and 3 cities to boost access. The government is providing tax relief to encourage this.
3) There is a shift from communicable to lifestyle diseases as incomes rise and urbanization grows. Around 50% of inpatient spending is now for issues like high cholesterol.
4) Management contracts are becoming more common as hospitals seek additional revenue streams. Home healthcare is also growing to save costs.
Similar to Emerging Healthcare Landscape of India: (20)
UC STRATEGY has covered a wide spectrum of financial services like broking firms, investment services, financial consulting, and numerous private banks.
UC STRATEGY offers Agribusiness, Food, and Agricultural consulting to International and Indian multinational companies for assistance in the form of varied service lines like India Entry Strategy, Go-To-Market Strategy, Growth Strategy and Commercial Due Diligence to effectively cater to the rural market. We also help companies in Supply Chain Strategy, Channel Management Strategy and Distribution Strategy.
UC STRATEGY team interacted extensively with members from operating companies to gain
a wholistic understanding of business and its requirements. UC Strategy conducted ~45 interviews with customers and competition.
UC STRATEGY offers Agribusiness, Agricultural, and Food Consulting across the value chain i.e. Agrochemicals & Seeds, Agriproduce & Processing Agri-machinery & Equipment.
The Japanese client manufactures yeast for bread and other bioproducts. They requested UC Strategy to assess the market for bread improver, atta, and maida in India. UC Strategy conducted primary and secondary research on market dynamics, key suppliers and brands, prices, distributors, and market sizes for these products. The client obtained insights to help enter the Indian market.
UC Strategy also assessed opportunities for a Ugandan cable company to diversify. They shortlisted and deeply analyzed opportunities in switchgear, batteries, honey, and chili. UC Strategy developed go-to-market strategies considering competition, feasibility, and the client's capabilities. This helped the client identify potential new product categories.
Additionally,
UC STRATEGY has covered a wide spectrum of financial services like broking firms, investment services, financial consulting, and numerous private banks.
UC STRATEGY offers Agribusiness, Agricultural, and Food Consulting across the value chain i.e. Agrochemicals & Seeds, Agriproduce & Processing Agri-machinery & Equipment.
India is the largest producer of milk in the world, producing over 65 million metric tonnes per year in 2017. However, it also has the lowest milk yield per animal at 1.8 tonnes per year. The Indian dairy market is largely unorganized, with around 80% of the market being informal in 2017. The industry is expected to see revenue growth of 15% annually to reach $85 billion by 2020. Key challenges for competitors in the Indian dairy market include product quality issues, inadequate understanding of customer demand, limited brand awareness, and the dominance of large companies. The document outlines strategies that different players in the industry could adopt related to customers, products, pricing, channels, and governance.
UC STRATEGY has covered a wide spectrum of financial services like broking firms, investment services, banking & financial consulting, evergreen national banks, numerous private banks, mutual funds, car and home loans, equity market and other banking services. UC STRATEGY experience in the banking financial services spans across Growth Strategy, Business Plans and Feasibility Studies.
India is burdened with a substantial power deficit resulting in vast tracts of the country, living in the dark shadows of frequent power outages. The government has embarked on a number of initiatives to bridge this power deficit over the next decade.
Meanwhile, India’s hapless citizens have already invested around Rs 100,000 crores (US$ 20 billion) in power back-up equipment due to the poor reliability of grid power. Another Rs 30,000 crores (US$ 6 billion) is the recurring operating expenditure incurred to maintain back-up power equipment. Further, a large portion of this operational expenditure is diesel fuel which, is subsidised by the government.
Companies have traditionally performed a large range of functions in-house, regardless of internal capability, or criticality to the business. This was driven by the absence of dependable service providers to outsource to and partially because of insecurity. Most companies pursued vertical integration to control the value chain1. The 90s challenged this mindset when Hamel and Prahlad’s theory of core competence captured the imagination of CEOs worldwide. Core competence theory seemed to urge businesses to stay focused only on functions and processes that were core to the organization.
Universal Consulting hosted a Chinese delegation in India, comprising the Shanghai Municipal People Government Economic Commission and Shanghai Foreign Economic Relations and Trade Commission. The visit was organized in order for the delegation to understand the Indian IT industry and identify potential alliance/ business opportunities with Indian software companies. On this visit, the delegation discussed the attractiveness of Shanghai as a center for IT business.
More from UC STRATEGY (Universal Consulting India Pvt Ltd) (20)
HOW TO START UP A COMPANY A STEP-BY-STEP GUIDE.pdf46adnanshahzad
How to Start Up a Company: A Step-by-Step Guide Starting a company is an exciting adventure that combines creativity, strategy, and hard work. It can seem overwhelming at first, but with the right guidance, anyone can transform a great idea into a successful business. Let's dive into how to start up a company, from the initial spark of an idea to securing funding and launching your startup.
Introduction
Have you ever dreamed of turning your innovative idea into a thriving business? Starting a company involves numerous steps and decisions, but don't worry—we're here to help. Whether you're exploring how to start a startup company or wondering how to start up a small business, this guide will walk you through the process, step by step.
Understanding User Needs and Satisfying ThemAggregage
https://www.productmanagementtoday.com/frs/26903918/understanding-user-needs-and-satisfying-them
We know we want to create products which our customers find to be valuable. Whether we label it as customer-centric or product-led depends on how long we've been doing product management. There are three challenges we face when doing this. The obvious challenge is figuring out what our users need; the non-obvious challenges are in creating a shared understanding of those needs and in sensing if what we're doing is meeting those needs.
In this webinar, we won't focus on the research methods for discovering user-needs. We will focus on synthesis of the needs we discover, communication and alignment tools, and how we operationalize addressing those needs.
Industry expert Scott Sehlhorst will:
• Introduce a taxonomy for user goals with real world examples
• Present the Onion Diagram, a tool for contextualizing task-level goals
• Illustrate how customer journey maps capture activity-level and task-level goals
• Demonstrate the best approach to selection and prioritization of user-goals to address
• Highlight the crucial benchmarks, observable changes, in ensuring fulfillment of customer needs
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSS
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...my Pandit
Dive into the steadfast world of the Taurus Zodiac Sign. Discover the grounded, stable, and logical nature of Taurus individuals, and explore their key personality traits, important dates, and horoscope insights. Learn how the determination and patience of the Taurus sign make them the rock-steady achievers and anchors of the zodiac.
Storytelling is an incredibly valuable tool to share data and information. To get the most impact from stories there are a number of key ingredients. These are based on science and human nature. Using these elements in a story you can deliver information impactfully, ensure action and drive change.
Structural Design Process: Step-by-Step Guide for BuildingsChandresh Chudasama
The structural design process is explained: Follow our step-by-step guide to understand building design intricacies and ensure structural integrity. Learn how to build wonderful buildings with the help of our detailed information. Learn how to create structures with durability and reliability and also gain insights on ways of managing structures.
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Final ank Satta Matka Dpbos Final ank Satta Matta Matka 143 Kalyan Matka Guessing Final Matka Final ank Today Matka 420 Satta Batta Satta 143 Kalyan Chart Main Bazar Chart vip Matka Guessing Dpboss 143 Guessing Kalyan night
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Tastemy Pandit
Know what your zodiac sign says about your taste in food! Explore how the 12 zodiac signs influence your culinary preferences with insights from MyPandit. Dive into astrology and flavors!
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
Digital Marketing with a Focus on Sustainabilitysssourabhsharma
Digital Marketing best practices including influencer marketing, content creators, and omnichannel marketing for Sustainable Brands at the Sustainable Cosmetics Summit 2024 in New York
Building Your Employer Brand with Social MediaLuanWise
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
How to Implement a Strategy: Transform Your Strategy with BSC Designer's Comp...Aleksey Savkin
The Strategy Implementation System offers a structured approach to translating stakeholder needs into actionable strategies using high-level and low-level scorecards. It involves stakeholder analysis, strategy decomposition, adoption of strategic frameworks like Balanced Scorecard or OKR, and alignment of goals, initiatives, and KPIs.
Key Components:
- Stakeholder Analysis
- Strategy Decomposition
- Adoption of Business Frameworks
- Goal Setting
- Initiatives and Action Plans
- KPIs and Performance Metrics
- Learning and Adaptation
- Alignment and Cascading of Scorecards
Benefits:
- Systematic strategy formulation and execution.
- Framework flexibility and automation.
- Enhanced alignment and strategic focus across the organization.
[To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
This PowerPoint compilation offers a comprehensive overview of 20 leading innovation management frameworks and methodologies, selected for their broad applicability across various industries and organizational contexts. These frameworks are valuable resources for a wide range of users, including business professionals, educators, and consultants.
Each framework is presented with visually engaging diagrams and templates, ensuring the content is both informative and appealing. While this compilation is thorough, please note that the slides are intended as supplementary resources and may not be sufficient for standalone instructional purposes.
This compilation is ideal for anyone looking to enhance their understanding of innovation management and drive meaningful change within their organization. Whether you aim to improve product development processes, enhance customer experiences, or drive digital transformation, these frameworks offer valuable insights and tools to help you achieve your goals.
INCLUDED FRAMEWORKS/MODELS:
1. Stanford’s Design Thinking
2. IDEO’s Human-Centered Design
3. Strategyzer’s Business Model Innovation
4. Lean Startup Methodology
5. Agile Innovation Framework
6. Doblin’s Ten Types of Innovation
7. McKinsey’s Three Horizons of Growth
8. Customer Journey Map
9. Christensen’s Disruptive Innovation Theory
10. Blue Ocean Strategy
11. Strategyn’s Jobs-To-Be-Done (JTBD) Framework with Job Map
12. Design Sprint Framework
13. The Double Diamond
14. Lean Six Sigma DMAIC
15. TRIZ Problem-Solving Framework
16. Edward de Bono’s Six Thinking Hats
17. Stage-Gate Model
18. Toyota’s Six Steps of Kaizen
19. Microsoft’s Digital Transformation Framework
20. Design for Six Sigma (DFSS)
To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations
48. AMSTERDAM
QVARTZ
Piet Hein Buildings – Wit, 8e etage
Piet Heinkade 95a, Amsterdam
Netherlands +31 6 11000204
HAMBURG
QVARTZ
Neuer Wall 40, DE-20354
Hamburg, Germany +49 40 298 13 470
NEW YORK CITY
QVARTZ
1185 Ave. of the Americas, 3rd floor, Suite 213
New York, NY 10036, USA +1 646 492 9913
SINGAPORE
QVARTZ
One George Street, Level 10-01
Singapore 049145 +65 91 59 94 17
COPENHAGEN
QVARTZ
Ryesgade 3A, DK-2200
Copenhagen N, Denmark +45 33 17 00 00
MUMBAI
UNIVERSAL CONSULTING INDIA PVT LTD
Shivsagar Estate D
Dr Annie Besant Road, Worli
Mumbai 400018, India +91 22 66222100
OSLO
QVARTZ
Wergelandsveien 21, NO-0167
Oslo, Norway +47 22 59 36 00
STOCKHOLM
QVARTZ
Birger Jarlsgatan 7, SE-111 45
Stockholm, Sweden +46 (0)8 614 19 00
If you would like to schedule a meeting to discuss this document, please email us at strategy@universalconsulting.com